As the hepatitis B virus is widely spread and responsible for considerable morbidity and mortality, WHO recommends vaccination from infancy to reduce acute infection and chronic carriers. However, current subunit vaccines are not 100% efficacious and leave 5–10% of recipients unprotected.
Japanese scientists at the Biomedical Research Institute at the National Institute of Advanced Industrial Science and Technology have created hens that can lay “golden eggs” containing a protein used to treat cancer and hepatitis. These scientists used new genome editing technology to create the hens that can lay multi-million pound golden eggs with high quantities of human interferon beta at a low cost.
HCV is a global and national concern with treatments being easily available for free, or at subsidized rates, across the country and in neighbouring States like Manipur, Meghalaya and Mizoram. However in Nagaland, HCV treatment and testing facilities are still not accessible or available for the general population.
“Setting targets under the National Viral Hepatitis Control Programme, the Indian health ministry had pledged to achieve 100% usage of ingineered safety devices to curtail injection related infections,” said Dr Chandrakant Lahariya, WHO-India.
It is more cost effective to treat hepatitis C sooner rather than later, regardless of the stage of the disease, and despite the high cost of patented drugs. However, patented drugs are being produced globally for prices much lower than those seen in the UK. Therefore, negotiation of patented drug prices with pharmaceutical companies may be a crucial step in cost effective treatment of hepatitis C.
Cocrystal, a clinical stage biotechnology company, announced today the completion of patient enrollment in its Phase 2a clinical study evaluating CC-31244 for the ultra-short treatment of hepatitis C virus (HCV)-infected individuals.
The village of Wularhama, in Pahalgam, sits on the Bijbehara-Pahalgam road where complaints of illnesses related to hepatitis C had grown to an alarming level in recent times. At least 150 people in a remote village of Pahalgam have tested positive for hepatitis C in what has set alarm bells ringing in the health department that if measures are not taken to stop the spread of the infection, it could transmit to areas beyond the village.
Hepatitis B, a viral infection affecting the liver, is the leading cause of liver cancer in Africa, accounting for up to 80 per cent of liver cancer cases. This is despite the infection being preventable through vaccination.
The number of hepatitis patients is on the rise in Peshawar province owing to lack of awareness regarding the causes of viral ailment, according to health experts. Studies showed that the existence of the illness was higher in Khyber Pakhtunkhwa than other parts of the country because the people of the province didn’t have information about the causative agents of the disease.
In Sukkur, Pakistan, the seriously sick patients of hepatitis A and C are running from pillar to post for critical medicines that are no longer available at the Hepatitis Center Khairpur for almost a month, jeopardizing the life of thousands of registered patients.